Histological and biological evolution of human premalignant breast disease - PubMed (original) (raw)
Review
Histological and biological evolution of human premalignant breast disease
D C Allred et al. Endocr Relat Cancer. 2001 Mar.
Abstract
Most human invasive breast cancers (IBCs) appear to develop over long periods of time from certain pre-existing benign lesions. Of the many types of benign lesions in the human breast, only a few appear to have significant premalignant potential. The best characterized of these include atypical hyperplasias and in situ carcinomas and both categories are probably well on along the evolutionary pathway to IBC. Very little is known about earlier premalignant alterations. All types of premalignant breast lesions are relatively common but only a small proportion appear to progress to IBC. They are currently defined by their histological features and their prognosis is imprecisely estimated from indirect epidemiological evidence. Although lesions within specific categories look alike, they must possess underlying biological differences causing some to remain stable and others to progress. Recent studies suggest that they evolve by highly diverse genetic mechanisms and research into these altered pathways may identify specific early defects that can be targeted to prevent premalignant lesions from developing or becoming cancerous. It is far more rational to think that breast cancer can be prevented than cured once it has developed fully. This review discusses histological models of human premalignant breast disease that provide the framework for scientific investigations into the biological alterations behind them and examples of specific biological alterations that appear to be particularly important.
Similar articles
- Premalignant and in situ breast disease: biology and clinical implications.
Arpino G, Laucirica R, Elledge RM. Arpino G, et al. Ann Intern Med. 2005 Sep 20;143(6):446-57. doi: 10.7326/0003-4819-143-6-200509200-00009. Ann Intern Med. 2005. PMID: 16172443 - Biological features of premalignant disease in the human breast.
Allred DC, Mohsin SK. Allred DC, et al. J Mammary Gland Biol Neoplasia. 2000 Oct;5(4):351-64. doi: 10.1023/a:1009573710675. J Mammary Gland Biol Neoplasia. 2000. PMID: 14973381 Review. - Biological and molecular characteristics of the premalignant mouse mammary gland.
Medina D. Medina D. Biochim Biophys Acta. 2002 Oct 2;1603(1):1-9. doi: 10.1016/s0304-419x(02)00053-7. Biochim Biophys Acta. 2002. PMID: 12242106 Review. - High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer.
Hoogerbrugge N, Bult P, de Widt-Levert LM, Beex LV, Kiemeney LA, Ligtenberg MJ, Massuger LF, Boetes C, Manders P, Brunner HG. Hoogerbrugge N, et al. J Clin Oncol. 2003 Jan 1;21(1):41-5. doi: 10.1200/JCO.2003.02.137. J Clin Oncol. 2003. PMID: 12506168
Cited by
- Radiological Society of North America (RSNA) 3D Printing Special Interest Group (SIG) clinical situations for which 3D printing is considered an appropriate representation or extension of data contained in a medical imaging examination: breast conditions.
Arribas EM, Kelil T, Santiago L, Ali A, Chadalavada SC, Chepelev L, Ghodadra A, Ionita CN, Lee J, Ravi P, Ryan JR, Sheikh AM, Rybicki FJ, Ballard DH; RSNA Special Interest 3D Printing Breast Conditions Voting Group. Arribas EM, et al. 3D Print Med. 2023 Mar 23;9(1):8. doi: 10.1186/s41205-023-00171-1. 3D Print Med. 2023. PMID: 36952139 Free PMC article. - Investigating isoform switching in RHBDF2 and its role in neoplastic growth in breast cancer.
Masood M, Masood MBE, Us Subah N, Shabbir M, Paracha RZ, Rafiq M. Masood M, et al. PeerJ. 2022 Nov 25;10:e14124. doi: 10.7717/peerj.14124. eCollection 2022. PeerJ. 2022. PMID: 36452073 Free PMC article. - Oncological safety of active surveillance for low-risk ductal carcinoma in situ - a systematic review and meta-analysis.
Davey MG, Lowery AJ, Kerin MJ. Davey MG, et al. Ir J Med Sci. 2023 Aug;192(4):1595-1600. doi: 10.1007/s11845-022-03157-w. Epub 2022 Sep 16. Ir J Med Sci. 2023. PMID: 36112315 Review. - The value of imaging combined with clinicopathological features in the diagnosis of high-risk breast lesions.
Zhou J, Sun S, Lin L, Jiang T, Hu X, Gu Y, You C. Zhou J, et al. Gland Surg. 2022 Aug;11(8):1323-1332. doi: 10.21037/gs-22-155. Gland Surg. 2022. PMID: 36082087 Free PMC article. - Are Columnar Cell Lesions the Earliest Non-Obligate Precursor in the Low-Grade Breast Neoplasia Pathway?
Strickland S, Turashvili G. Strickland S, et al. Curr Oncol. 2022 Aug 11;29(8):5664-5681. doi: 10.3390/curroncol29080447. Curr Oncol. 2022. PMID: 36005185 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical